In: Accounting
a.
Merck |
|||
INCOME STATEMENT |
Year 3 Estimate |
Year 2 |
Year 1 |
Net sales |
47,716 |
40,343 |
|
Cost of goods |
28,977 |
22,444 |
|
Gross profit |
18,739 |
17,900 |
|
Selling general & administrative expense |
6,531 |
6,469 |
|
Depreciation & amortization expense |
1,464 |
1,277 |
|
Interest expense |
342 |
329 |
|
Income before tax |
10,403 |
9,824 |
|
Income tax expense |
3,121 |
3,002 |
|
Net income |
7,282 |
6,822 |
|
Outstanding shares |
2,976 |
2,976 |
2,968 |
RATIOS |
|||
Sales growth |
18.27% |
18.27% |
|
Gross Profit Margin |
39.27% |
39.27% |
|
Selling General & Administrative Exp / Sales |
13.69% |
13.69% |
|
DEPRECIATION (depn exp / pr yr PPE gross) |
8.76% |
8.76% |
|
INT (int / pr yr LTD) |
4.94% |
4.94% |
|
Tax (Inc Tax / Pre-tax inc) |
30.00% |
30.00% |
|
BALANCE SHEET |
Year 3 Estimate |
Year 2 |
Year 1 |
Cash |
3,287 |
4,255 |
|
Receivables |
5,215 |
5,262 |
|
Inventories |
3,579 |
3,022 |
|
Other |
880 |
1,059 |
|
Total current assets |
12,961 |
13,598 |
|
Property, plant & equipment |
18,956 |
16,707 |
|
Accumulated depreciation |
5,853 |
5,225 |
|
Net property & equipment |
13,103 |
11,482 |
|
Other assets |
17,942 |
15,075 |
|
Total assets |
44,007 |
40,155 |
|
Accounts payable & accrued liabilities |
5,904 |
5,391 |
|
Short-term debt & cmltd |
4,067 |
3,319 |
|
Income taxes |
1,573 |
1,244 |
|
Total current liab |
11,544 |
9,954 |
|
Deferred income, taxes and other |
11,614 |
11,768 |
|
Long term debt |
4,799 |
3,601 |
|
Total liabilities |
27,957 |
25,323 |
|
Common stock |
30 |
30 |
|
Capital surplus |
6,907 |
6,266 |
|
Retained earnings |
31,500 |
27,395 |
|
OTHER EQUITIES |
0 |
0 |
|
Treasury stock |
22,387 |
18,858 |
|
Shareholder equity |
16,050 |
14,832 |
|
Total liabilities & net worth |
44,007 |
40,155 |
|
RATIOS |
|||
AR turn |
9.15 |
9.15 |
7.67 |
INV turn |
8.10 |
8.10 |
7.43 |
AP turn |
4.91 |
4.91 |
4.16 |
Tax Pay (Tax pay / tax exp) |
50.41% |
50.41% |
41.45% |
FLEV (Assets/Equity) |
2.35 |
2.74 |
2.71 |
Div/sh |
$1.06 |
$1.06 |
$0.98 |
CAPEX |
5,100 |
4312 |
3641 |
CAPEX/Sales |
9.04% |
9.04% |
9.03% |
Additional Balance Sheet Assumptions:
Other Current Assets- Unchanged
Other Assets- Unchanged
Deferred Income Taxes & Other- Unchanged
Short Term Debt & CMLTD- Unchanged
Long Term Debt- Unchanged
Required:
1)Prepare the estimated Year 3 projected income statement using the ratios provided.
2)Prepare the estimated Year 3 projected balance sheet using the ratios and assumptions provided. Remember that cash is your residual account to make the balance sheet, balance.
3)Assuming that Merck requires an ending 6.5% cash balance for sales projected in Year 3, does it have a ‘surplus’ or a ‘deficit’ of cash relative to the requirement. By how much? If a deficit, suggest how the deficit might be financed. If a surplus, suggest how it might be used.
Income Statement | |||
$ | % of Variable | Variable Cost | |
Sales | 1,200,000 | ||
Cost of goods sold | 800,000 | 75% | 600,000 |
Gross profit | 400,000 | ||
Operating expenses -Selling | 280,000 | 42% | 117,600 |
Administrative | 150,000 | 40% | 60,000 |
Net Profit(Loss) | (30,000) | ||
Total Variable Expenses (600000+117600+60000) | $777600 | ||
Total Fixed Expenses (800000+280000+150000) - 777600 | $452400 | ||
So Contribution | |||
1200000-777600 = 422,400 | |||
% 0f Contribution = 422400/1200000 = 35.20% | |||
Contribution per unit 422,400 / 240000 = 1.76 | |||
Break-even Point in units | |||
Fixed Expenses / Contribution per unit | |||
452400/1.76 = 257045 units | |||
Break-even Point in Doller | |||
452400 /35.20% | |||
$1285227 |